| Progress in understanding the biology of the human mutagen LINE‐1 DV Babushok, HH Kazazian Jr Human mutation 28 (6), 527-539, 2007 | 272 | 2007 |
| Efficacy and safety of hydroxychloroquine vs placebo for pre-exposure SARS-CoV-2 prophylaxis among health care workers: a randomized clinical trial BS Abella, EL Jolkovsky, BT Biney, JE Uspal, MC Hyman, I Frank, ... JAMA internal medicine 181 (2), 195-202, 2021 | 225 | 2021 |
| Current topics in genome evolution: molecular mechanisms of new gene formation DV Babushok, EM Ostertag, HH Kazazian Cellular and molecular life sciences 64, 542-554, 2007 | 189 | 2007 |
| Diagnosis and treatment of aplastic anemia SA Peslak, T Olson, DV Babushok Current treatment options in oncology 18, 1-20, 2017 | 148 | 2017 |
| Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults DV Babushok, M Bessler, TS Olson Leukemia & lymphoma 57 (3), 520-536, 2016 | 148 | 2016 |
| Emergence of clonal hematopoiesis in the majority of patients with acquired aplastic anemia DV Babushok, N Perdigones, JC Perin, TS Olson, W Ye, JJ Roth, C Lind, ... Cancer genetics 208 (4), 115-128, 2015 | 136 | 2015 |
| L1 integration in a transgenic mouse model DV Babushok, EM Ostertag, CE Courtney, JM Choi, HH Kazazian Genome research 16 (2), 240-250, 2006 | 120 | 2006 |
| Somatic HLA mutations expose the role of class I–mediated autoimmunity in aplastic anemia and its clonal complications DV Babushok, JL Duke, HM Xie, N Stanley, J Atienza, N Perdigones, ... Blood advances 1 (22), 1900-1910, 2017 | 98 | 2017 |
| Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria L Sun, DV Babushok Blood, The Journal of the American Society of Hematology 136 (1), 36-49, 2020 | 92 | 2020 |
| Genetic predisposition syndromes: when should they be considered in the work-up of MDS? DV Babushok, M Bessler Best practice & research Clinical haematology 28 (1), 55-68, 2015 | 80 | 2015 |
| Recent advances in understanding clonal haematopoiesis in aplastic anaemia N Stanley, TS Olson, DV Babushok British journal of haematology 177 (4), 509-525, 2017 | 76 | 2017 |
| Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients A Ganetsky, JH Han, ME Hughes, DV Babushok, NV Frey, SI Gill, ... Clinical Infectious Diseases 68 (12), 2003-2009, 2019 | 70 | 2019 |
| Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia AH Matthews, AE Perl, SM Luger, AW Loren, SI Gill, DL Porter, ... Blood Advances 6 (13), 3997-4005, 2022 | 68 | 2022 |
| A novel testis ubiquitin-binding protein gene arose by exon shuffling in hominoids DV Babushok, K Ohshima, EM Ostertag, X Chen, Y Wang, PK Mandal, ... Genome Research 17 (8), 1129-1138, 2007 | 68 | 2007 |
| Clonal evolution and clinical significance of copy number neutral loss of heterozygosity of chromosome arm 6p in acquired aplastic anemia M Betensky, D Babushok, JJ Roth, PJ Mason, JA Biegel, TM Busse, Y Li, ... Cancer genetics 209 (1-2), 1-10, 2016 | 59 | 2016 |
| Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract A Ganetsky, NV Frey, EO Hexner, AW Loren, SI Gill, SM Luger, ... Bone marrow transplantation 54 (2), 212-217, 2019 | 53 | 2019 |
| Myeloproliferative neoplasms with concurrent BCR–ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group CR Soderquist, MD Ewalt, DR Czuchlewski, JT Geyer, HJ Rogers, ED Hsi, ... Modern Pathology 31 (5), 690-704, 2018 | 52 | 2018 |
| Clonal hematopoiesis in patients with dyskeratosis congenita N Perdigones, JC Perin, I Schiano, P Nicholas, JA Biegel, PJ Mason, ... American journal of hematology 91 (12), 1227-1233, 2016 | 51 | 2016 |
| Poor outcome with hematopoietic stem cell transplantation for bone marrow failure and MDS with severe MIRAGE syndrome phenotype J Sarthy, J Zha, D Babushok, A Shenoy, JM Fan, G Wertheim, ... Blood advances 2 (2), 120-125, 2018 | 40 | 2018 |
| Prevention and treatment of COVID-19 with hydroxychloroquine (PATCH) investigators. Efficacy and safety of hydroxychloroquine vs placebo for pre-exposure SARS-CoV-2 prophylaxis … BS Abella, EL Jolkovsky, BT Biney, JE Uspal, MC Hyman, I Frank, ... JAMA Intern Med 181 (2), 195-202, 2021 | 39 | 2021 |
Yimei LiAssociate Professor of Biostatistics, University of Pennsylvania & The Children's Hospital ofVerificeret mail på chop.edu
